Back to the main directory
EarningsReview / Equity
- Alfa Laval (Buy, TP: SEK340.00) - Smooth sailing into the summer by DnB Markets
- Adevinta (Hold, TP: NOK160.00) - Recovery in progress by DnB Markets
- Valmet (Buy, TP: EUR42.00) - Still plenty of room to expand by DnB Markets
- Hennes & Mauritz (Buy, TP: SEK250.00) - Dressed for success by DnB Markets
- Sats (Hold, TP: NOK24.00) - by DnB Markets
- SSAB (Buy, TP: SEK57.00) - Looking around the corner by DnB Markets
- A strange old year; upgrading to Outperform by BNP Paribas Exane
- Full steam ahead by BNP Paribas Exane
- TCS Group - Increasing Risks of Capital Raise? by Sberbank
- Positive updates & management feedback by HSBC
- Novo Nordisk (Hold, TP: DKK560.00) - Down to HOLD after a good run by DnB Markets
- Elektroimportøren (Buy, TP: NOK100.00) - Showing resilience in a tough market by DnB Markets
- TGS Nopec (Sell, TP: NOK100.00) - A weak Q2e well flagged by DnB Markets
- Transactions and other news by DnB Markets
- Stolt-Nielsen (Buy, TP: NOK150.00) - Positive outlook intact by DnB Markets
- Looking beyond the short term by BNP Paribas Exane
- East versus West by BNP Paribas Exane
- G7 commitment, but further to go before COP26 by BNP Paribas Exane
- The weekly navigator by DnB Markets
- The lights are staying on by BNP Paribas Exane
- PROSUS: RDOS. 2021 (ANÁLISIS BANCO SABADELL) by Sabadell
- EQUITA SIM: OVS (BUY; Unchanged): 1Q21 Results - Entering the reopening phase in strong shape by Equita Sim
- Naspers and Prosus by HSBC
- The penultimate episode in the GrandVision saga by BNP Paribas Exane
- Strong ecommerce delivery by BNP Paribas Exane
- Catena (Hold, TP: SEK500.00) - Downgraded on valuation by DnB Markets
- Getinge (Buy, TP: SEK350.00) - Another strong quarter expected by DnB Markets
- Neles (Buy, TP: EUR13.30) - Waiting for Valmet; up to BUY by DnB Markets
- Castellum (Buy, TP: SEK250.00) - Looking for the last 1.8% by DnB Markets
- XXL (Buy, TP: NOK25.00) - Mixed spring, brighter summer by DnB Markets
- Foschini (TFG SJ) by HSBC
- Manchester Divided? by BNP Paribas Exane
- A good long-term story by BNP Paribas Exane
- If expectations are low, our optimism is high (and 15qs) by BNP Paribas Exane
- Lundin Mining (Buy, TP: SEK105.00) - Yield machine on Chile uncertainty by DnB Markets
- Aker Biomarine (Hold, TP: NOK84.00) - Set for another mixed quarter by DnB Markets
- Skistar (Buy, TP: SEK160.00) - A leading Nordic holiday operator in the making by DnB Markets
- Alimak (Hold, TP: SEK145.00) - Eyes on the prize by DnB Markets
- Equinor (Hold, TP: NOK190.00) - 4% Renewables IRR favoured over 30% Oil & Gas IRR by DnB Markets
- Feedback from CEO conference by BNP Paribas Exane
- SITC International (1308 HK) by HSBC
- Investment Daily 18/06/2021 by BNP Paribas Exane
- Orphazyme - FDA says no and issues CRL to arimoclomol in NPC by Danske Bank Equity Research
- Sector title by DnB Markets
- Investment Daily 21/06/2021 by BNP Paribas Exane
- 巨星科技（002444 CH） by HSBC
- Policemen of the Transition by BNP Paribas Exane
- ITC (ITC IN) by HSBC
- CARIGE is on the block by BNP Paribas Exane
- CEO conference feedback by BNP Paribas Exane